Info

🌱來自: renal-cell-carcinoma

Non-clear cell histology

Clinical trial preferred Therapy extrapolated from clear cell; anti-VEGF agents w/ ↑ RR vs. mTOR inhibitors. Some response to chemo in selected cases

Siblings

• Epidemiology
• Histology and molecular biology
• Hereditary RCC and germline testing
• Clinical presentation
• Staging (TNM classification) and prognosis
• Treatment principles
• Systemic therapy for metastatic clear cell RCC
• Second-line therapies
• Combined-modality therapies
• Tyrosine kinase inhibitors
• Immunotherapies
• mTOR inhibitors
• Non-clear cell histology